Prostate Cancer
Selective ablation of TRA-1-60+ pluripotent stem cells suppresses tumor growth of prostate cancer.
May 11, 2023
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer.
May 11, 2023